The 14 most recent market catalysts affecting $OSCR, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.
Sep 18, 2026
Corporate Catalyst
Bullish
Impact 55
Raymond James Maintains Outperform on Oscar Health, Raises Price Target to $42
Raymond James analyst John Ransom has maintained an 'Outperform' rating on Oscar Health and raised the price target from $34 to $42. This indicates a strengthened positive outlook …
Sep 17, 2026
Corporate Catalyst
Bullish
Impact 75
OSCR stock has given up its prior gain. Oscar Health shares were trading higher after Barclays and Baird raised their respective price targets on the stock.
This headline highlights a classic 'buy the rumor, sell the news' or 'overbought' scenario, where positive analyst sentiment initially drove gains, but the stock couldn't sustain t…
Sep 17, 2026
Corporate Catalyst
Bullish
Impact 55
B of A Securities Maintains Underperform on Oscar Health, Raises Price Target to $30
BofA Securities analyst Adam Ron maintained an 'Underperform' rating on Oscar Health (OSCR), signaling a continued bearish stance on the company's fundamentals or future prospects.…
Sep 17, 2026
Corporate Catalyst
Bullish
Impact 75
Oscar Health Stock Rises Following Raised 2026 Guidance and Wall Street Price Target Hikes
Oscar Health's Investor Day presentation and subsequent 8-K filing revealed a material improvement in its full-year 2026 financial guidance, specifically a $100 million increase in…
Sep 17, 2026
Corporate Catalyst
Bullish
Impact 75
Oscar Health shares are trading higher after Barclays and Baird raised their respective price targets on the stock.
The upward revision of price targets by Barclays and Baird signals a positive shift in analyst sentiment towards Oscar Health. This often leads to increased buying pressure as inst…
Sep 17, 2026
Corporate Catalyst
Bullish
Impact 55
Barclays Maintains Overweight on Oscar Health, Raises Price Target to $49
Barclays analyst Andrew Mok maintained an 'Overweight' rating on Oscar Health and raised the price target from $39 to $49. This action signals continued confidence from a prominent…
Sep 16, 2026
Corporate Catalyst
Neutral
Impact 75
Oscar Health Reaffirms Raises FY26 Earnings From Operations Guidance From $500M-$700M To $600M-$800M; Reaffirms FY26 Sales Guidance Of $18.7B-$19B
Oscar Health announced an upward revision to its full-year 2026 earnings from operations guidance, increasing it by $100 million to a new range of $600 million to $800 million. Thi…
Aug 13, 2026
Corporate Catalyst
Bullish
Impact 55
Wells Fargo Maintains Equal-Weight on Oscar Health, Raises Price Target to $27
Wells Fargo analyst Stephen Baxter maintained an 'Equal-Weight' rating on Oscar Health but raised the price target from $20 to $27. This action signals a slightly more optimistic v…
Aug 7, 2026
Corporate Catalyst
Bullish
Impact 55
Barclays Maintains Overweight on Oscar Health, Raises Price Target to $39
Barclays analyst Andrew Mok has maintained an 'Overweight' rating on Oscar Health (OSCR) and raised the price target from $35 to $39. This action signals continued confidence from …
Aug 6, 2026
Corporate Catalyst
Bearish
Impact 75
Oscar Health Raises Outlook But Warns CMS Membership Churn Will Pick Up
Oscar Health delivered impressive second-quarter results, exceeding analyst expectations for both revenue and earnings, and improved its medical loss ratio. The company also reaffi…
Aug 6, 2026
Corporate Catalyst
Bearish
Impact 75
Oscar Health are trading lower. The stock initially rallied premarket after the company reported Q2 financial results, but it has since reversed.
The initial premarket rally suggests that Oscar Health's Q2 results contained positive surprises or met high expectations. However, the subsequent reversal indicates that investors…
Aug 6, 2026
Corporate Catalyst
Bearish
Impact 55
Oscar Health Affirms FY2026 Sales Guidance of $18.700B-$19.000B vs $18.623B Est
Oscar Health filed an 8-K to affirm its fiscal year 2026 sales guidance, reiterating a range of $18.700 billion to $19.000 billion. This is a routine disclosure when a company want…
Aug 6, 2026
Corporate Catalyst
Neutral
Impact 75
Oscar Health Q2 Total Members 2.963M (+46$ Y/Y)
Oscar Health's 8-K filing reveals a robust 46% year-over-year increase in total members, reaching 2,963,002 as of June 30, 2026, compared to 2,027,148 in the prior year. This growt…
Aug 6, 2026
Corporate Catalyst
Bullish
Impact 95
Oscar Health Q2 EPS $1.10 Beats $0.49 Estimate, Sales $4.882B Beat $4.751B Estimate
Oscar Health announced impressive Q2 results, with earnings per share of $1.10 significantly surpassing analyst estimates of $0.49, and sales of $4.882 billion beating the $4.751 b…
Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.